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Abstract
Timely, and sometimes rapid, metabolic adaptation to changes in food supply is critical for survival as an organism moves
from the fasted to the fed state, and vice versa. These transitions necessitate major metabolic changes to maintain energy
homeostasis as the source of blood glucose moves away from ingested carbohydrates, through hepatic glycogen stores,
towards gluconeogenesis. The integration of hepatic glycogen regulation with extra-hepatic energetics is a key aspect of
these adaptive mechanisms. Here we use computational modeling to explore hepatic glycogen regulation under fed and
fasting conditions in the context of a whole-body model. The model was validated against previous experimental results
concerning glycogen phosphorylase a (active) and glycogen synthase a dynamics. The model qualitatively reproduced
physiological changes that occur during transition from the fed to the fasted state. Analysis of the model reveals a critical
role for the inhibition of glycogen synthase phosphatase by glycogen phosphorylase a. This negative regulation leads to
high levels of glycogen synthase activity during fasting conditions, which in turn increases substrate (futile) cycling, priming
the system for a rapid response once an external source of glucose is restored. This work demonstrates that a mechanistic
understanding of the design principles used by metabolic control circuits to maintain homeostasis can benefit from the
incorporation of mathematical descriptions of these networks into ‘‘whole-body’’ contextual models that mimic in vivo
conditions.
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Introduction
Glucose is the major metabolic fuel of mammals, with its
maintenance at appropriate levels within the body being crucial
for normal function, while dysregulation is associated with diseases
such as diabetes mellitus, galactosemia and glycogen storage
diseases [1]. Maintaining glucose levels requires a highly
responsive control system capable of balancing a wide range of
environmental conditions, perhaps the most basic of which is
managing the uptake of nutrients from food at irregular time
intervals. Specifically, transitions between fed and fasted states
require rapid shifting between the storage of excess glucose, in the
form of glycogen, within the liver and muscle and the breakdown
of these stores for delivery of glucose to other organs. In healthy
individuals, proper functioning of this system ensures that available
nutrients are efficiently captured and stored during times of excess,
while effectively managed and distributed during times of fasting.
The rate with which the organism responds to these changes
can play a critical role in survival. Optimization of energy storage
is essential during competition for sparse food supplies, while rapid
delivery of these energy supplies during hasty retreat from
predators can mean the difference between life and death [2]. A
key player in energetics, especially for erythrocyte and brain
function, is blood glucose concentration.
The liver is the central organ for regulation of glucose and
glycogen and acts as the primary distributor of nutrients through
the blood to other tissues. When in a fasted state, the liver breaks
down glycogen stores, producing glucose for other tissues. After a
meal, the liver switches to a glucose consuming state, capturing
nearly 26% of the glucose presented to it by the portal system
during the first passage [3]. Nearly 10–15% [4,5] of liver weight is
comprised of glycogen stores when filled.
Glucose regulation within the liver is performed by the glycogen
circuit that controls both the storage of glucose as glycogen
(glycogenesis) as well as its breakdown into glucose-6-phosphate
from hepatic stores (glycogenolysis). Of significance is the fact that
glycogenolysis and glycogenesis are not the result of a single
reversible reaction, but rather are two separate, highly-regulated
pathways. Two key molecular players within these pathways are
glycogen synthase (GS) and glycogen phosphorylase (GP). GS
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multiple mechanisms including allosteric activation, covalent
modification, as well as enzymatic translocation [6–8]. GP
catalyzes the rate-limiting step in glycogenolysis and it too, is
actively regulated through phosphorylation at a single residue on
the NH2 terminus as well as through allosteric regulation [6–8].
Both these enzymes exist in activated (GSa and GPa) as well as
inactivated (GSb and GPb) states.
As the synthesis of glycogen and its breakdown into glucose
occur through separate pathways, there is the potential for
substrate cycling to occur, wherein glucose and glycogen are
continuously interconverted. In fact, the glycogen circuit exhibits
different behaviors depending on the state of liver glycogen levels
(Figure 1). In the fed state, glucose is plentiful in the blood and
glycogen levels within the liver are relatively high, resulting in the
activation of GS and the synthesis of glycogen. When a fasting
state is entered, glycogen levels in the liver are high and blood
glucose levels are maintained by the breakdown of this glycogen
into glucose-6-phosphate by GPa. Finally, when in the fully fasted
state, glycogen stores within the liver are essentially depleted. It is
here, in the context of glycogen depletion, that cycling is observed
between glycogen and glycose-6-phosphate [9,10].
It has long been suggested that substrate cycling is a generic
mechanism that can potentially improve such properties as
sensitivity and system response time, allowing net synthesis when
there is a small offset in the substrate concentrations [7,10–13].
However, demonstrations of cycling and its functional relevance in
a physiological context are still relatively rare. In this work, we
were particularly interested in investigating the potential role of
the cycling - no cycling architecture of the glycogen circuit
manifested during the transition from a fed to a fasted state. While
the benefit of preventing substrate cycling is apparent since energy
is dissipated in the form of heat during this process, it is not clear
why it is beneficial for glycogen to cycle under the fasted state, as
shown in Figure 1.
Mathematical models, which provide one way to explore such
questions, have been applied successfully to many biological fields,
but their application has been limited in the case of the nutritional
sciences [14]. The number of mathematical models of hepatic
energy metabolism, as it relates to hepatic glycogen storage, has
been slowly increasing in response to interest in the impact of
exercise on energetics in the case of diabetes [14], diet [15] and
athletic training [16]. In addition, large-scale reconstructions of
metabolism, typically based on flux or constraint-based models,
have recently been developed for multiple organ systems including
the liver [17–21]. These stochiometry-based approaches can be
used to analyze the relevant biological network solely based upon
systemic mass-balance and reaction capacity constraints when
kinetic information is missing [22,23]. However, as these
approaches are based on steady state assumptions and do not
consider specific kinetic properties, they provide a fundamentally
different view of metabolism and metabolic dynamics than
detailed mechanistic models.
In the absence of a suitable model for the present work, we
developed a physiological model based on a central control
glycogen circuitry by Hers et al. [7] and Mutalik et al. [24], with
the whole body bioenergetics described in [25–29] as well as the
Figure 1. Liver glycogen levels control circuit architecture. Glycogen is synthesized by GSa and broken down into glucose-6-phosphate by
GPa. Glycogen levels within the liver are shown in the Fed, Fasting and Fasted state as shaded boxes, with full liver glycogen stores being shown as a
solid black box in the Fed portion of the circuit. Arrows indicate which branch of the pathway is active. Substrate cycling occurs in the glycogen-
depleted (empty box), Fasted state.
doi:10.1371/journal.pcbi.1002272.g001
Author Summary
Homeostasis of blood glucose concentrations during
circadian shifts in survival-related activities, sleep and food
availability is crucial for the survival of mammals. This
process depends upon glucose intake, short-term storage
as glycogen, and gluconeogenesis. The integration of
hepatic glycogen anabolic and catabolic dynamics with
whole body energetics is critical for survival. In this paper
we use computational modeling to investigate the
potential survival advantage of substrate (futile) cycling
of glycogen and glycogen precursors. Our simulations,
combined with published experimental results of other
researchers, indicate that as the body enters a state of
fasting, the activity of enzymes involved in the synthesis of
glycogen increases leading to increased substrate cycling.
This increase in substrate cycling allows the system to
respond more rapidly once new external sources of
glucose become available. The whole-body computational
model developed for this work allows the metabolic
control circuitry to be studied under simulated in vivo
conditions, providing functional insights that are not
evident when individual modules of glycogen regulatory
circuitry are examined in isolation.
A Whole-Body Model for Glycogen Regulation
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maintaining glucose homeostasis under different fed-fasting
conditions. We placed specific emphasis on investigating the role
of the cycling - no cycling architecture in metabolic functions.
Building on previous biochemical and quantitative modeling
descriptions, this model embedded the glycogen circuit of the liver
within a physiological system composed of muscle, adipose tissue
and blood compartments. By controlling the glucose injection rate
into the blood stream, we were able to simulate system response
across a broad range of fed/fasting conditions. Our simulation
results reproduced previously published experimental observations
and further indicated that the cycling design in Figure 1 provides a
mechanism for decreasing the amount of time it takes to convert
glucose to glycogen in the fasted state.
Results/Discussion
Model overview
We now give a brief overview of our model, with full details and
the complete set of model equations provided in Protocol S1. Note
that the complete MATLAB package together with the description
file are provided in Protocol S2 and S3, respectively. The SBML
code is also provided in Protocol S4 for a broader usage and
implementation. As noted earlier, glycogen is created from glucose
during feeding and is subsequently degraded to release glucose-6-
phosphate during fasting. The hepatic glycogen circuit controlling
this process is embedded within the hepatocyte at the center of our
physiological model (Figure 2). Blood is depicted as a closed loop,
being carried around the body to connect multiple tissue
compartments, including the liver, muscle, and fat. Thus blood
functions as a transport system within our model, providing the
resources needed to manufacture and store hepatic glycogen
during the fed state while carrying its major degradation product,
glucose, away during the fasted state for use by other tissues. The
liver is currently the most detailed compartment in this model,
including selected aspects of glycogenolysis, glycogenesis, glycol-
ysis, gluconeogenesis, the TCA cycle, lipogenesis, lipolysis and
ketogenesis (See Protocol S1 for model equations).
As an animal moves through the fed, fasting and fasted states, its
body switches to different types of metabolic fuels to stabilize blood
glucose concentration. This transition is controlled in large part by
the blood levels of insulin and glucagon, both of which are
generated in a reciprocal manner by the pancreas in response to
changing blood glucose levels. Insulin and glucagon are mutually
antagonistic with respect to many aspects of intermediary
metabolism and their effects on bioenergetics [25,34]. Insulin is a
key regulator for carbohydrate and fat metabolism in the body. It
enhances blood glucose uptake to form triglycerides and glycogen
and suppresses pathways such as gluconeogensis and glycogenolysis
[35]. Glucagon, on the other hand, is secreted from the pancreas
when blood glucose concentration is low. It inhibits glycolysis and
stimulates hepatic glycogenolysis and gluconeogenesis in liver by
increasing the concentration of cAMP [36]. The elevated level of
cAMP inturn activatesa cascade ofenzymes intheglycogencontrol
circuitry that enhance the degradation of glycogen molecules [7].
Insulin and glucagon, working in a reciprocal fashion, in
conjunction with other hormonal regulators, such as leptin and
epinephrine, maintain glucose homeostasis in biological systems.
Our physiological model also incorporates aspects of the Cori cycle,
where lactate from muscle and erythrocytes is carried to the liver
and converted to glucose for reuse by these tissues.
Blood glucose is provided from absorbed carbohydrates during
feeding up until digestion is complete, at which point hepatic
glycogen stores take over this role. Depletion of hepatic glycogen
occurs over a period of 12–24 hours, though this varies greatly with
activity levels [7,37]. Once hepatic glycogen stores are consumed,
blood glucose levels are maintained by gluconeogenesis. This
process uses energy derived from storage fat in the form of acetyl
CoA and the carbon skeletons of glycogenic amino acids. In the
present physiologicalmodel,glycogenicaminoacidsarerepresented
by alanine derived from muscle. The major sites of gluconeogenesis
are the kidney and the liver, with only the latter being represented
here. As blood glucose levels fall due to hepatic glycogen depletion,
blood insulin levels fall while glucagon levels rise, leading to
biochemical changes resulting in the use of alternative fuels in the
form of free fatty acids and ketones, and gluconeogenesis which
requires the use of such energy as mentioned above.
In tissues such as the heart and muscle, a number of factors
regulate the use of alternative energy sources in order to spare blood
glucose for use by erythrocytes (which depends solely on blood
glucose [38]) and the brain (which mainly depends on blood glucose
but can use ketone bodies as an alternative during fasting [39]). Our
general bioenergetic model includes a number of tissue and
biochemical components that were selected on the basis of their
relationship to glycogen metabolism. The timing of these events and
the dynamics of blood insulin, glucagon, glucose, free fatty acids,
ketones, and levels of hepatic glycogen stores in response to fasting
andfeedingcyclesfromoursimulationareshowninFigure3andare
consistent with those which were previously described in [25–29].
The cyclic-AMP (cAMP) induced glucose-glycogen
circuitry
Internal cues: cAMP activates a cascade of enzymes.
The glycogen circuitry is activated by intra- and extracellular
signals including cAMP, glucose and glucose-6-phosphate. As
blood glucose begins to fall in the post-absorptive state, glucagon is
secreted from the pancreas and causes elevation of cAMP levels
[36]. The increase in cAMP signal leads to activation of cAMP-
dependent protein kinase (CAPK), which in turn activates
phosphorylase kinase (PK). PK phosphorylates GS (less active, b-
form) and GP (more active, a-form) and drives the system to enter
a catabolic state where glycogen molecules are broken down to
supply liver glucose output and maintain blood glucose levels.
Note that GP can be inhibited directly by high levels of glucose
[10] as indicated in Figure 4. Protein phosphatase-1 (PP-1) is
another key element in this regulation, acting as the primary
phosphatase catalyzing the dephosphorylation of PK, GP, and GS.
A variety of evidence shows that GPa has an inhibitory effect on
the dephosphorylation (activation) of GS under fed conditions
[7,40], as shown on the bottom of Figure 4. This inhibition is
mediated by the direct binding of GPa to glycogen synthase
phosphatase (GS phosphatase), a major enzyme catalyzing the
conversion of GS from the D (b - phosphorylated, less active) to
the I (a - unphosphorylated, active) form. To model this inhibitory
effect, we incorporated the dissociation constant (Kd) between GPa
and GS phosphotase, as first proposed by Mutalik et al. [24]. As a
whole, the intracellular cAMP concentration determines the level
of activated kinases and phosphatases within the cell, which in turn
determines the levels of GPa and GSa and therefore the glycogen
degradation and synthesis rates [7,24].
As mentioned above, GPa inactivates GS phosphatase by direct
binding under the fed condition. In fact, Stalmans et al. [40]
observed that only after the levels of GPa dropped below 10% of
the total enzyme (a+b) would liver GS then be activated. It has also
been shown that the inhibition of GS phosphatase by GPa
depends on liver glycogen concentration and that a minimal
amount of glycogen is required for this inhibition [41,42].
Therefore, the level of inhibition of GS phosphatase by GPa is
A Whole-Body Model for Glycogen Regulation
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glucose and hormonal cues, as well as the internal state of liver
glycogen stores (indicated by a red arrow in Figure 4). Since this
inhibition is induced by direct binding of GPa to GS phosphatase,
one way to model the difference in inhibition is through the
dissociation constant (Kd) of these two enzymes, as first proposed
by Mutalik et al. [24]. Note that in their work, a Kd of
2|10{3mM was set to correspond to a fasted state while a Kd
of 2|10{3mM corresponded to a fed state. As described further
below, we similarly use the dissociation constant of GS
phosphatase and GPa as a means to model the discrepancy in
the enzymatic activities in fed and fasting states. For a detailed
discussion, we refer the readers to [24].
External cues: Insulin, glucagon and cAMP. Insulin and
glucagon are two key hormones that both regulate, and are
regulated by, blood glucose concentration. The concentrations of
these two hormones are governed by the equations [43]:
d½Bins 
dt
~kinsz
k1ins
1z(
kmins
½Bgluc 
)
ni
{kd Bins½Bins , ð1Þ
d½Bglucgn 
dt
~kglucgnz
k1glucgn
1z(
½Bgluc 
kmglucgn
)
ng
{kd Bglucgn½Bglucgn : ð2Þ
Figure 2. Diagrammatic representation of key features of the physiological model. The general design principles of the model are based
on established bioenergetic physiology [1]. The liver, placed at the center of this diagrammatic representation of ‘‘the body’’, contains the glycogen
circuitry which lies within hepatocytes connected to other organs by the vascular system (show in red). Blood within the vascular system travels
around the body, carrying materials between the liver and other organs, with a cycle time of about one minute. Key: Gluc=glucose; FFA=free fatty
acids; Ket=ketones; TAG=triacylglycerol; ACoA=acetyl CoA; Alan=alanine. Note that kidney, brain and erythrocytes are not included in the current
model.
doi:10.1371/journal.pcbi.1002272.g002
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kd Bglucgn are the degradation rates for insulin and glucagon,
respectively. We assume that the release rate of insulin into the
blood increases with glucose levels according to Hill kinetics with a
Hill coefficient of ni. The maximal insulin-induced release rate is
k1ins and the glucose concentration at which this rate is half its
maximum is kmins. Similarly, to model the decrease in glucagon at
high blood glucose levels, we assume the release rate of glucagon
decreases according to Hill kinetics. The Hill coefficient is ng, the
maximum induced release rate is k1glucgn, and the glucose
concentration at which the release rate is half its maximum is
kmglucgn. The values of the parameters in the above two equations
are chosen such that the concentrations of insulin and glucagon
are in the range of ½7|10{6,1:3|10{6 mM and ½3|10{8,
5|10{8 mM, taken from physiologically relevant ranges
determined from rodent studies [27].
cAMP is a secondary messenger that is regulated by both insulin
and glucagon. Following a drop in blood glucose levels, cAMP
activates CAPK according to the following reaction:
R2C2z2cAMP<R2CcAMP2zC
R2CcAMP2z2cAMP<R2CcAMP4zC
ð3Þ
The above reaction includes two steps and results in the release of
2 molecules of catalytic subunit C from CAPK by 4 molecules of
cAMP. The equation that governs the concentration of cAMP is
then [43]:
d½cAMP 
dt
~
kc1½Bglucgn 
ng
k
ng
cm1z½Bglucgn 
ng {
kc2½Bins 
ni
kni
cm2z½Bins 
ni ½cAMP 
{2kgc1½R2C2 ½cAMP 
2z2k{gc1½R2CcAMP2 ½C 
z2kgc2½R2CcAMP2 ½cAMP 
2{2k{gc2½R2CcAMP4 ½C ,
ð4Þ
w h e r ew ea s s u m eM i c h a e l i s - M e n t e nt y p ek i n e t i c sf o rt h e
regulatory functions of insulin and glucagon on cAMP. The
two Michaelis-Menten constants kcm1 and kcm2 were set to be
the mean values of the glucagon and insulin concentrations,
1|10{6mM and 4|10{8mM, respectively, while the
parameters involved in the activation of CAPK are adopted
from [24].
The amount of the catalytic subunit C determines the activity
level of GP and GS [7,24]. Together, these two enzymes regulate
the metabolism of liver glycogen: if GS is more active, the system
converts excessive glucose into glycogen for short-term storage; if
GP is mostly active, the system utilizes glycogen to make glucose to
supply the needs of other organs. The equation for the glycogen
concentration is [43]:
d½glyc 
dt
~
kL2½GSa ½g6p 
kmL2z½g6p 
{
k{L2½GPa ½glyc 
k{mL2z½glyc 
, ð5Þ
where again we use Michaelis-Menten kinetics to describe the
enzymatic activities.
Finally, the glucose concentrations in liver ½gluc  and blood
½Bgluc  are given in Equations (6) and (7) correspondingly [43],
where vtL1, vtF1 and vtS1 are the glucose transport rates from the
blood stream to liver, adipose tissue and muscle, vL1 and v{L1 are
the reaction rates for the conversion of glucose into g6p and g6p
back to glucose, vd Bgluc~0:015mM=min is the degradation
rate of blood glucose and vfeed is the feeding function for blood
glucose, which is subject to change under different feeding
patterns.
d½gluc 
dt
~vtL1{vL1zv{L1, ð6Þ
Figure 3. Simulation results: dynamic responses of selected hormones and substrates during a 24-hour fasting period. Note that
hormone and substrate concentrations are normalized by their maximum values during the simulation. Blood glucose concentration has a multiplier
of 0.8 to give a better view. Key: bl gluc=blood glucose; pl glucagon=plasma glucagon; pl ins=plasma insulin; pl FFA=plasma free fatty acids; bl
ket=blood ketone bodies.
doi:10.1371/journal.pcbi.1002272.g003
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dt
~vfeed{vtL1{vtF1{vtS1{vd Bgluc,
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ep1
k
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ep1
 !
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1z
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ep9
k
ep9
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 !
,
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ep12
k
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ep12
 !
,
vtS1~ktS1½Bgluc  1z
½Bins 
ep13
k
ep13
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ep13
 !
:
ð7Þ
The degree of substrate cycling depends upon the
dissociation constant Kd
Mutalik and Venkatesh [24] computed the dose response curves
of the enzymes in the glycogen circuitry based on their empirically
derived input functions for glucose-6-phosphate (G6p) and cAMP.
Again, we note that the dissociation constant (Kd)o fG S
phosphatase and GPa is the key factor in determining the amount
of substrate cycling at steady state. In fact, Mutalik et al. [24]
defined different physiological states based on the value of Kd,
where a smaller value (2|10{3mM) corresponded to a fed state
and a larger one (2|10{3mM) corresponded to a fasted state. We
followed a similar approach to construct the dose response curves
for these enzymes. Unlike [24], the glycogen circuitry was
incorporated into a 4-compartment physiological model. As a
result, the dynamics of cAMP and glucose-6-phosphate were
simulated directly within our model and the entire system can be
more realistically simulated by simply controlling the plasma
glucose concentration.
The dose-response curves for GSa and GPa at two specified
values of Kd are shown in Figure 5. Here, the system was run to
steady state with a fixed blood glucose concentration between
5 mM and 10 mM, the typical range for fed-fasting experiments in
Figure 4. The central control glycogen circuitry (modified from Figure 3.1 in [43]). Rectangles and circles enclose the names or
abbreviations of enzymes and substrates accordingly. The reactions as a result of an increase in cAMP concentrations are shown with bold arrows.
cAMP=cyclic adenosine monophosphate; R2C2=cAMP dependent protein kinase; C=R2C2 catalytic subunit; PKb=inactive phosphorylase kinase;
PKa=active phosphorylase kinase; GPb=inactive glycogen phosphorylase; GPa=active glycogen phosphorylase; GSb=inactive glycogen
phosphorylase; GSb=inactive glycogen synthase; GSa=active glycogen synthase; P=phosphate; g-6-p=glucose-6-phosphate; PP1, protein
phosphatase-1.
doi:10.1371/journal.pcbi.1002272.g004
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2|10{3mM to 2|10{3mM, the crossover point of GPa and
GSa shifted from a higher glucose concentration to a lower one
(from 7:45mM to 6:70mM) with a correspondingly higher
activated fraction (from 5% to 60%). This fraction represents the
maximum percentage of both enzymes being active simultaneous-
ly, thus it is an indicator of the degree of substrate cycling in the
system. We note that the inhibitory effect by GPa on the activation
of GS through direct binding to GS phosphatase is partially
released with a larger Kd.
The response time for glycogen synthesis decreases with
a larger value of Kd in the glycogen depleted state
From the above discussion, it is apparent that the inhibition of
GS activation by GPa through direct regulation of GS
phosphatase varies with the state of fasting. With a larger Kd,
the maximum amount of substrate cycling (co-activated fraction of
GS and GP) is higher at the steady state. Here, we further
investigated the dynamics of GS and GP but in the context of a
glycogen depleted liver.
To simulate the response of the system to glucose in a glycogen
depleted state, we provided a constant input of glucose with
Kd~10{3mM and ran the simulation to steady state. We then
gradually throttled back the glucose input, and waited until liver
glycogen was completely depleted. Glucose supply then re-
entered the blood stream as a step function at t=0, after which
the dynamics of hormone, enzyme and substrate responses were
observed. The results for two values of Kd, Kd~10{3mM and
Kd~10{3mM are shown in Figure 6A. Note that the
observation period began at t~0. A detailed description of the
plasma glucose feeding function F1(t) is provided in Figure S5 in
Protocol S1.
Figures 6A–B show selected enzyme activities and glycogen
concentration as a function of time. Note that ‘‘glycogen
concentration’’ here and in the later context refers to the amount
of glucose converted to glycogen as one molecule of glycogen
comprises an indeterminate number (hundreds or thousands) of
glucose subunits. At t~0, liver glycogen stores are completely
depleted and GP is mostly active (over 70% in the a-form). The
sudden increase in the blood glucose concentration drove the
transition from a GP-dominant to GS-dominant scenario. There
was a major difference in when and where the intersection of GPa
and GSa activity curves occurred for the two selected values of Kd.
Under Kd~2|10{3mM, the point of intersection occurred at
60% and t~13:4mins (Figure 6A-left panel). In contrast, this
point shifted to 5% and t~30:6mins with Kd~2|10{3mM
Figure 6B-right panel.
Figure 6B showed the liver glycogen concentration as a function
of time. Again, the observations started at t~0 where the blood
glucose supply resumed. Readily apparent was the slow but nearly
immediate increase in the glycogen concentration at t~0 under
Kd~2|10{3mM (black line with dots). Recall that at this value,
the level of inhibition of GS phosphatase by GPa was much
reduced, allowing the coexistence of 60% of GSa and GPa. In
contrast, the liver glycogen concentration remained at a negligible
level until t~27mins with Kd~2|10{3mM (solid line with
squares) where substrate cycling was reduced to 5%. Therefore,
the system was able to respond quickly to the glucose stimulus and
drive an immediate synthesis of glycogen with a higher level of
substrate cycling. In both cases, a dramatic change in the synthesis
rate of glycogen occurred where GSa and GPa intersect (15 mins
and 30.6 mins correspondingly).
We next further investigated the relationship between the
system response time and the level of substrate cycling in a
glycogen depleted liver. Instead of two values of Kd (marked by a
red square (2|10{3mM) and triangle (2|10{3mM) in Figure 7),
we considered a range of values from 2|10{3mM to
5|10{3mM. There are two different ways to define the system
response time to glucose stimulus: (1) the time when the GSa and
GPa curves intersect or (2) the time when glycogen concentration
exceeds a threshold value. We selected a threshold value of
0.5 mM, the glycogen concentration reached at the end of the
simulation (t~40mins) with the smallest Kd~2|10{3mM. The
time response curves under both definitions were shown in
Figure 7A as a blue and black line respectively. The differences in
the response time shown on both curves were on the order of
30 mins between the largest and smallest Kd. In Figure 7B, we
provided the co-active percentage of GS and GP at the
intersection point.
The results from this analysis provide a possible explanation as
to why the biological system has different metabolic mechanisms
(different Kd) under different fasting states. In a glycogen-depleted
state, it is essential to have a highly responsive system, ready for
replenishing energy reserves as soon as nutrients become available.
Our simulation results clearly showed that the high degree of
substrate cycling occurring in the fasted state accelerated the
system response in this respect by about 30 minutes, which would
be physiologically significant for survival. Conversely, avoiding
substrate cycling in a fed state is also desirable from an energy
Figure 5. Fractional activation of GPa and GSa plotted against blood glucose concentration under two selected K0
ds. A:
Kd~2|10{3mM corresponds to a stronger binding between glycogen phosphorylase a (GPa) and GS phosphatase, which results in a strong
inhibition on the activation of glycogen synthase (GSa). B: Kd~2|10{3mM corresponds to a weaker binding between GPa and GS phosphatase,
where the inhibition by GPa is partially relieved.
doi:10.1371/journal.pcbi.1002272.g005
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GS, GP, glucose 1-phosphate uridylytransferase and nucleoside
diphosphate kinase result in an ATP consuming reaction
(ATPzH2O?ADPzPi).
Comparison with experiments
We have shown that the level of inhibition of GS phosphatase
by GPa through the dissociation constant Kd, or equivalently the
level of substrate cycling, determined the system response time in a
Figure 6. Time evolutions curves of selected enzymes and substrates. A: Time response curves of GSa and GPa under two selected K0
ds after
glucose stimulus enters blood stream at t~0 in a glycogen depleted liver. Crossover of GSa and GPa occurs at 13.4 and 30.6 minutes respectively. B:
Liver glycogen concentration plotted against time under the two selected K0
ds.
doi:10.1371/journal.pcbi.1002272.g006
Figure 7. Enzymes and substrate responses over a series of Kd ranging from 2|10-3mM to 0:5|10-2mM. A: System response time to
glucose stimulus plotted against Kd in a glycogen depleted liver. Blue: system response time defined by the cross-over point of glycogen synthase a
(GSa) and glycogen phosphorylase a (GPa). Black: system response time defined by the time when liver glycogen concentration exceeds 0.5 mM.
Note that the difference in system response time is about 30 mins for the lowest and highest values of Kd selected here under both definitions. B:
The co-activated percentage of GSa and GPa at the cross-over point as a function of Kd. Note that this percentage represents the maximum co-active
percentage of both enzymes, hence it is an indicator of the level of substrate cycling in the system. The points inside the rectangles
(Kd~2|10{3mM) and triangles (Kd~2|10{3mM) are the two values chosen in Figure 6.
doi:10.1371/journal.pcbi.1002272.g007
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inhibition is glycogen dependent [41,42]. Watts et al. [47]
reported that the GS phosphatase activity decreased in the livers
of fasted, fed and gsd/gsd (liver glycogen storage disorder) mice
and the addition of glycogen to homogenates of liver from starved
rats reduced the glycogen synthase phosphatase activity. More
recently, Armstrong et al. [48] pointed out that there are unique
binding sites for GPa, PP-1 and glycogen in the hepatic glycogen-
targeting subunit of protein phosphatase 1 (PP1{GL), a GS
phosphatase specific to liver. Therefore, it is reasonable to assume
that this inhibitory regulation changes according to the liver
glycogen level. We modeled this effect by using the following
expression for the dissociation constant Kd:
Kd~(Kmax
d {Kmin
d )
1
1z
½glyc 
kd mg
   n zKmin
d ð8Þ
where [glyc] is the liver glycogen concentration,
Kmax
d ~3:2|10{3mM, Kmin
d ~2|10{3mM, kd mg~5mM and
the Hill constant n~5. Note that the parameters were chosen to
match the experimental results of [49] as shown in Figure 8.
We compared our model predictions to experimental studies
that investigated GS and GP levels within fed and fasted livers in a
rodent model system [49]. In this work, Hue et al. measured GP
and GS activities over time in isolated hepatocytes under
sequential changes to the glucose concentration (from 5.5 mM
to 55 mM) in the incubation medium. Results from this study were
redrawn in Figure 8.
It is important to note that we are comparing a ‘‘whole-body’’
simulation with results obtained from cultured cells which are not
interacting with events driven by other tissues, such as fat and
muscle. However, this comparison demonstrates clear similarities
between these cell culture data and our simulations with respect to
responses of the glycogen regulatory circuitry to blood glucose
concentrations. We started our simulation at the fed steady state
and fasted the model system to two different times, 250 mins and
1200 mins, to represent fed and fasted livers respectively. In the
simulation for fed livers, 250 mins fasting time was chosen to
recreate a fasting environment as seen at the beginning of the
experiments (Figure 8A), where GP is mostly in the active form
and over 90% GS is in the inactive form [49]. Note that after
250 mins, the liver glycogen level was at about 75% of the fed
steady state. In the simulation for fasted livers, 1200 mins was
chosen after which only less than 1% glycogen remained. We then
compared the response from both livers under 4 different glucose
feeding rates (kf~0:2,0:4,0:6and1:4mM=min), as shown in
Figure 9. Since we made our observation only after glucose
supply re-entered the blood stream, we shifted the simulation time
forward to 250 mins and 1200 mins in the fed and fasted livers
and denoted them as t~0.
Multiple aspects of our simulation results matched reported
experimental observations of [49]. For instance, simulations and
experiments showed the activation of GS to be highly suppressed
by GPa in the fed state. For the lowest glucose injection rate,
kf~0:2mM=min, GS is not activated at all, which was also
observed in experiments by Hue et al. (Figure 8A). Both the
experimental and simulation results showed that the active
percentage of GS was higher in the fasted than in the fed state
at the end of the experiment/simulation (t~20mins). Further-
more, in both experimental studies and simulations, GS always
responded more rapidly (on the order of 10–15 minutes as defined
by the cross-over point of GSa and GPa) in the glycogen-depleted
compared to the fed state. As the injection rate of glucose
increased, the response time of GSa was shortened. Note that the
glycogen concentrations from our simulation are provided in
Figure S6 in Protocol S1, which also indicated a quicker response
from the fasted livers. Although we can accurately capture the
changes in response time under different glucose concentrations, it
is clear that we have only addressed limited aspects of the relevant
metabolic pathways and associated regulatory components. For
instance, it is known that bioenergetics is regulated by a number of
mechanisms including push-pull [50] and negative feedback, the
latter being an integral component of our whole-body and
glycogen-specific models. Furthermore, transcript level regulation
is required to capture variations in enzyme concentration that
occur under different fasting conditions. Such investigations lie
outside the scope of the current model.
Conclusions
The cells, tissues, organs, bodies and populations of all living
organisms are in a constant state of sensing and response to
numerous external and self-generated stimuli [51]. Feedback
loops, both positive and negative, play intrinsic roles in
homeostatic regulation of biological systems. Negative feedback
loops underpin the majority of the balances of nature, from
predator-prey relationships to biochemical networks, and are
clearly subjected to evolutionary pressures [52]. Negative feedback
is a common mode of control for signaling networks [53], reducing
time required to reach steady states [30], providing a mechanism
for reducing fluctuations in protein expression levels and pathway
activity. In contrast to stabilizing activity, in the presence of
sufficient time delays, negative feedback can have destabilizing
effect and generate overshooting and random oscillations,
rendering noise a challenging issue in the modeling of biochemical
networks [54]. No attempt was made to incorporate stochasticity
into the present investigations. Biological systems employ negative
feedback combined with controlled time delays as a means of
inducing functional oscillations. Such internally generated oscilla-
tions are responsible in large part for circadian rhythms and the
cell cycle [55], which are intimately linked to the subject of feed-
fasting cycles in the present work.
In this work, we have developed a physiological model that
simulates selected major components of bioenergetics as outlined
in [25–27]. The outer general bioenergetics model (outer ring of
Figure 2) was created as a ‘‘test bed’’ [56,57] for the glycogen
circuit, which permits simulation of the glycogen regulatory
circuitry in response to physiological changes that mimic the
effects of fasting and feeding on whole-body energetics. As we
could find no such testbed for the hepatic glycogen regulatory
circuit that we were investigating, and as such circuits interact in
potentially unpredictable ways with other body systems via the
vascular, nervous, and other communication systems, we endeav-
ored to build such a software platform for our investigations.
Analysis of this model suggests that the glycogen circuit’s context-
dependent (fed or fasted) architecture allows for a significant
increase in response time when the organism is in a fasted state.
Suppression of substrate cycling in the fed state could provide a
strategy for energy conservation leading to optimal energy storage.
The current work also provides a platform for further
investigation into bioenergetic diseases such as diabetes and
glycogen storage disease (GSD). Type VI and type IX GSD,
representing 25–30% of the total cases, are either due to a
deficiency in glycogen phosphorylase or an abnormality in the
enzyme that activates it [58]. Therefore, it is crucial to understand
glucose-glycogen metabolism in a whole body environment,
especially the regulatory mechanisms for some of the key enzymes
A Whole-Body Model for Glycogen Regulation
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phosphorylase. Interestingly, this work could also be of value for
research into optimization of nutrition protocols for athletes or
soldiers who are required to perform under stress. Glycogen
supercompensation, where glycogen storage ability is increased
following glycogen depletion when consuming a high carbohy-
drate diet, is an important issue for performance in athletes.
Numerous studies have been carried out to investigate the
relationship between the amount and type of carbohydrate
ingestion and the maximum glycogen resynthesis rate [59–61].
Of related interest, a study by Roberts et al. [62] demonstrated
that metabolism of simple sugars leads to a higher glycogen
resynthesis rate than that generated through the metabolism of
complex carbohydrates. Under the current computational model
Figure 8. Previous experimental results by Hue et al. Glycogen phosphorylase a (GPa) and glycogen synthase a (GSa) activities in hepatocytes
under fed (A) and fasted conditions (B) are redrawn from experimental results by Hue et al. [49]). From left to right, top to bottom in panel A and B: 4
increasing glucose concentrations from 5.5 to 55 mM in the incubation medium caused a sequential inactivation of glycogen phosphorylase and
activation of glycogen synthase.
doi:10.1371/journal.pcbi.1002272.g008
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PLoS Computational Biology | www.ploscompbiol.org 10 December 2011 | Volume 7 | Issue 12 | e1002272Figure 9. Simulation results by computational modeling (a parallel comparison to Figure 8). Glycogen synthase a (solid circles) and
glycogen phosphorylase a (open circles) activities are plotted against time under 4 different glucose input rate in fed (A) and fasted livers (B). From
left to right, top to bottom: vfeed~0:2,0:4,0:6,1:4mM=min. Note that the y-axis is the active to total enzyme percentage.
doi:10.1371/journal.pcbi.1002272.g009
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continuous parameter space, and an optimal nutrition plan for
these individuals might be predicted by taking into account energy
flows. Computational models, such as the one developed here,
could assist in the design of nutrition plans for athletes and
individuals suffering from bioenergetic challenges, including
diabetes.
Materials and Methods
One of the goals of our metabolic model was to capture key
features of the dynamics of internal energy sources, from fed
through fasted states, to include blood glucose, liver glycogen,
FFAs, and ketone bodies, regulated by plasma glucagon and
insulin. The dynamics of these substrates and enzymes are
described in [25–27], while the whole body energetics have been
reviewed in [26,28,29]. A summary of these time events is given in
[63]. Such a simulation would then provide a dynamic framework
within which to test the behavior of the underlying control
circuitry, as for glycogen in the present study. When the
physiological system enters the fasting state, blood glucose
concentration drops, flipping a reciprocal switch with respect to
plasma insulin and glucagon concentrations [28,36]. cAMP then
responds and transmits a signal to the glycogen circuitry to
regulate the activities of GP and GS [7]. As a result, hepatic
glycogen is being depleted as it is catabolized to maintain blood
glucose levels within the physiological range needed for survival.
The level of plasma free fatty acids and ketone bodies also rise to
provide alternative metabolic fuels. A diagram of the concentra-
tions of selected metabolites with respect to time after fasting
commences is available in Figure 3. Except for the similar
characteristic behaviors described previously in [25–29], our
model is also able to capture the damped oscillations at the
beginning of a new local stable state.
Metabolic pathways
Here we give a brief overview of the four major compartments
in our liver-centered physiological model, as shown in Figure 2.
For a detailed description of these pathways, model equations and
parameters, please refer to Protocol S1. A detailed parameter-
based sensitivity analysis has also been conducted and results
revealed that blood glucose is not sensitive to 10-fold changes in
the parameters that describe the activity of each enzyme. The
results are provided in Table S8–S10 in Protocol S1.
Liver. As a center of bioenergetic regulation, the liver is able
to convert glucose that is surplus to immediate energy demands
into a short term energy storage form, glycogen, and utilize it to
maintain blood glucose homeostasis during the early stages of
fasting. Besides its regulatory functions in glycogenesis and
glycogenolysis, the liver is also capable of processing amino acids
and free fatty acids from muscle and adipose tissue, respectively, to
stabilize the blood glucose level when hepatic glycogen is depleted.
Recognizing its irreplaceable role in metabolism, the liver is
modeled extensively within our physiological network. The eight
simplified pathways in the liver include glycolysis, gluconeogenesis,
glycogenesis, glycogenolysis, TCA cycle, lipogenesis, lipolysis and
ketogenesis.
Adipose tissue. As mentioned above, glycogen is a effective
short term energy reserve because it can be catabolized quickly to
satisfy a urgent need for glucose. In terms of long term energy
storage, however, it is not as effective as triglycerides, which is a
much more compact energy storage device which is largely
contained within adipose tissues. Since our model is focused on the
liver’s role in metabolism, a brief sketch of the metabolic
interactions between this organ and those in the fat and muscle
tissue are included in our simulations. An important role of fat is
that glucose is taken up by fat in an insulin-dependent manner and
is stored as triacylglycerol within fat as an energy depot that is
available to drive gluconeogenesis when blood glucose levels drop
and glucose generation is needed. The conversion of glucose into
and free fatty acids in fat tissue are described in Protocol S1. The
only metabolites modeled for fat tissue are glucose-6-phosphate,
acyl-CoA, triacylglycerol and free fatty acids.
Muscle. Muscle is another major site for glycogen storage.
However, muscle glycogen cannot contribute directly to plasma
glucose since muscle lacks glucose-6-phosphatase, an important
enzyme in the gluconeogenesis pathway. Instead, the end product
of glycolysis, pyruvate, can either form lactate or alanine (our
representative for amino acids and proteins), to be transported to
the liver. Alanine is a direct substrate for gluconeogenesis in liver
while lactate assists in the maintenance blood glucose level through
the Cori cycle, in which lactate is used in gluconeogenesis in liver.
In our model, muscle is modeled as a sink term for metabolic fuels
such as glucose and ketone bodies and also an alternative energy
source to provide lactate and alanine. The metabolites modeled
for muscle are glycogen, glucose-6-phosphate, pyruvate, lactate,
alanine and ketone bodies.
Blood. For simplification, all the metabolic processes (except
for degradation) are ignored in the blood. It only serves as a
transport system, conveying nutrients between the major organs
simulated by the model.
All the transport processes described above are shown in Figure
S4 in Protocol S1 and a more detailed description is also provided
there.
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